Knight Ridder/Tribune Business News - FDA approves generic version of popular Abbott Laboratories thyroid drug.
By Bruce Japsen, Chicago Tribune Knight Ridder/Tribune Business News
Jun. 25–The Food and Drug Administration has cleared the way for cheaper generic copies of Abbott Laboratories’ popular thyroid drug Synthroid, the second-most prescribed medication in the United States.
Although Synthroid has been on the market for more than 50 years, it has never faced direct generic competition because it predated modern FDA rules and regulations.
Most Popular
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?
Business Plan Sample
But after years of haggling with Abbott and previous owners of Synthroid, the agency finally reviewed the thyroid drug market and …
Read the rest of this article with a Free Trial at HighBeam Research.
